View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Wedbush Research
  • Wedbush Research
2454 MEDIATEK INC.
LOGN LOGITECH INTERNATIONAL S.A.
VMW VMWARE INC. CLASS A
QRVO QORVO INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
WDC WESTERN DIGITAL CORPORATION
VYGR VOYAGER THERAPEUTICS INC.
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SBUX STARBUCKS CORPORATION
RWT REDWOOD TRUST INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
PCRX PACIRA BIOSCIENCES INC.
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
MCD MCDONALD'S CORPORATION
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FTNT FORTINET INC.
FATE FATE THERAPEUTICS INC
EXLS EXLSERVICE HOLDINGS INC.
EAT BRINKER INTERNATIONAL INC.
DENN DENNY'S CORPORATION
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
AXTI AXT INC.
ARDX ARDELYX INC
SWKS SKYWORKS SOLUTIONS INC.
FRX_CN FENNEC PHARMACEUTICALS
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
TMHC TAYLOR MORRISON HOME CORPORATION
HPE HEWLETT PACKARD ENTERPRISE CO.
TWTR TWITTER INC.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
AVGO BROADCOM INC.
HEAR TURTLE BEACH CORP.
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
PINS PINTEREST INC. CLASS A
BCEL ATRECA
DELL DELL TECHNOLOGIES INC CLASS C
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
LC LENDINGCLUB CORP
SMCI SUPER MICRO COMPUTER
AQST INC.
IDYA AQUESTIVE THERAPEUTICS
PASG IDEAYA BIOSCIENCES
BDTX PASSAGE BIO
ACET BLACK DIAMOND THERAPEUTICS
CRSR ADICET BIO INC
ITOS CORSAIR GAMING
ZNTL ITEOS THERAPEUTICS
PRAX ZENTALIS PHARMACEUTICALS
FUBO PRAXIS PRECISION MEDICINES
TVTX FUBOTV
LSEA TRAVERE THERAPEUTICS INC
VRDN LANDSEA HOMES CORP (A)
DAWN VIRIDIAN THERAPEUTICS INC
ELEV DAY ONE BIOPHARMACEUTICALS INC
OMGA ELEVATION ONCOLOGY
LBPH OMEGA THERAPEUTICS
THRX LONGBOARD PHARMACEUTICALS
MRVL THESEUS PHARMACEUTICALS
STX INC.
DSGN MARVELL TECHNOLOGY INC
ATXS SEAGATE TECHNOLOGY HLDGS PLC
AVTE DESIGN THERAPEUTICS INC
GFS ASTRIA THERAPEUTICS INC
RLYB AEROVATE THERAPEUTICS INC
KRTX GLOBALFOUNDRIES INC
FUSN RALLYBIO CORP
VIGL KARUNA THERAPEUTICS INC
EWTX FUSION PHARMACEUTICALS INC
VIGIL NEUROSCIENCE INC
EDGEWISE THERAPEUTICS INC
 PRESS RELEASE

Assemblée Générale Mixte des Actionnaires d’Air Liquide du 30 avril 20...

PARIS--(BUSINESS WIRE)-- Regulatory News: L’Assemblée Générale des Actionnaires d’Air Liquide (Paris:AI), présidée par Benoît Potier, Président du Conseil d’Administration, en présence de François Jackow, Directeur Général, des membres du Conseil d’Administration, et de Jérôme Pelletan, Directeur Financier, a réuni 3 225 personnes, ce mardi 30 avril 2024, au Palais des Congrès de Paris. Les Actionnaires, qui représentaient 57,91 % des droits de vote, soit 86 061 Actionnaires présents ou représentés, ont adopté l’ensemble des résolutions présentées. Benoît Potier, Président du Conseil d’Adm...

BASF SE: 1 director

A director at BASF SE bought 5,000 shares at 48.573EUR and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

 PRESS RELEASE

TotalEnergies : Déclaration des Transactions sur Actions Propres

PARIS--(BUSINESS WIRE)-- Regulatory News: Paris, le 29 avril 2024 - Dans le cadre de l’autorisation consentie par l’Assemblée générale ordinaire du 26 mai 2023 pour opérer sur ses actions et conformément à la réglementation relative aux rachats d'actions, TotalEnergies SE (LEI : 529900S21EQ1BO4ESM68)  (Paris:TTE) (LSE:TTE) (NYSE:TTE) déclare ci-après les achats d’actions propres (FR0000120271) réalisés du 22 avril au 26 avril 2024 : Jour de la transaction Volume total journalier (en nombre de titres) Prix pondéré moyen journalier d'acquisition (en EUR/action) Montant de...

Pierre FerraguÊ
  • Pierre FerraguÊ

Tesla portfolio expansion; cloud revenues and capex accelerating; time...

As always, during earnings season, we start the week with a wrap-up of what happened in the previous week.

Ahmed Ben Salem
  • Ahmed Ben Salem

TotalEnergies : Stronger Q1 results –group considering shifting its ma...

>Q1 2024 results 2.2% higher than forecast - Adjusted net income came in at $ 5.1bn, 2.2% ahead of our forecasts and the consensus and off a sequential 2.2% with higher WC and debt.Favourable environment, reassuring message on LNG - In E&P, net operating income came in at $ 2.5bn, 2% ahead of the consensus. Production was stable at 2.46m boe/d. Adjusted for disposals in Canada, it showed growth of 1%. For Q2, the group’s guidance is for a slight dec...

Ahmed Ben Salem
  • Ahmed Ben Salem

TotalEnergies : Résultats T1 supérieurs – Le groupe songe à déplacer s...

>Résultats T1 2024, 2.2% supérieurs aux attentes - Le RNpg ajusté s'est établi à 5.1 Md$, 2.2% supérieur à nos attentes et au consensus et en baisse séquentielle de 2.2% avec une hausse du BFR et de l’endettement.Un environnement favorable, message rassurant sur le GNL - En E&P, le RO net ajusté ressort à 2.5 Md$, 2% supérieur au consensus. La production est restée stable à 2.46 Mbep/j. Ajustée des cessions au Canada, elle ressort en hausse de 1%. P...

Daniel Ives ... (+4)
  • Daniel Ives
  • John Katsingris
  • Sam Brandeis
  • Steven Wahrhaftig
Daniel Ives ... (+4)
  • Daniel Ives
  • John Katsingris
  • Sam Brandeis
  • Steven Wahrhaftig
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Ahmed Ben Salem
  • Ahmed Ben Salem

TotalEnergies : Q1 results beat expectations by 2.2%, increased gearin...

>Q1 2024 beat expectations by 2.2% - Adjusted attributable net profit was $ 5,112m, 2.2% above our expectations and the consensus (ODDO BHF: $ 4,997m, consensus: $ 5,000m). Production came in at 2,461 kboe/d, flat q-o-q and down 2.5% y-o-y following the divestment in Canada. In E&P, adjusted net operating profit was $ 2,550 m (vs $ 2,802m in Q4), reflecting lower gas prices. Resilient iLNG and robust refining margins with reassuring outlook - In iL...

Ahmed Ben Salem
  • Ahmed Ben Salem

TotalEnergies : Q1 results beat expectations by 2.2%, increased gearin...

>Q1 2024 beat expectations by 2.2% - Adjusted attributable net profit was $ 5,112m, 2.2% above our expectations and the consensus (ODDO BHF: $ 4,997m, consensus: $ 5,000m). Production came in at 2,461 kboe/d, flat q-o-q and down 2.5% y-o-y following the divestment in Canada. In E&P, adjusted net operating profit was $ 2,550 m (vs $ 2,802m in Q4), reflecting lower gas prices. Resilient iLNG and robust refining margins with reassuring outlook - In iL...

 PRESS RELEASE

Le Conseil d’administration de TotalEnergies réaffirme la pertinence d...

PARIS--(BUSINESS WIRE)-- regulatory News: TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE): Le Conseil d’administration a examiné, lors de sa séance du 25 avril 2024, la proposition de résolution déposée par un groupe d’actionnaires représentant moins de 0,9 % du capital et tendant à soumettre à l’Assemblée Générale un vote consultatif demandant au Conseil d’administration d’adopter une dissociation de la Présidence du Conseil d’administration et de la Direction générale de la Société. Le Conseil d’administration de TotalEnergies réaffirme son attachement fort au dialogue actionnarial e...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch